Stay in touch with NCATS by connecting via social media, joining our listserv for frequent announcements, and subscribing to our monthly e-newsletter.
Explore the full spectrum of translational science, including NCATS' role in transforming knowledge into treatments.
These maps provide a common framework for discussing the therapeutic development process.
Review a list of all the innovative programs and initiatives that NCATS supports.
Read about the 10th annual Rare Disease Day at NIH, an award-winning technology for drug development, an NCATS-Eli Lilly externship, a new strategic plan for toxicity testing, and more.
On March 1, 2018, patients, scientists, policymakers and others participated in the 10th annual Rare Disease Day at NIH.
To address challenges in drug development, NCATS supported research on a device designed to make the pre-clinical drug testing process more efficient and reliable.
Leaders of the Toxicology in the 21st Century (Tox21) program have published a strategic and operational plan to address new research challenges.
Through the NCATS-Eli Lilly externship, CTSA Program Scholar Josephine Taverna, M.D., learns new approaches to drive her research forward.
View Assay Guidance Manual training workshop vidoes.
Scientists have developed a potential new approach to fighting cancer.
Christopher P. Austin, M.D.
View funded activities under the NCATS Clinical and Translational Science Awards Program. (PDF - 80KB)
Interested in creating biologically, physiologically and pharmacologically relevant assays for early-stage drug discovery? Check out our best-practices Assay Guidance Manual.
Learn more about all the ways that potential grantees, partners and collaborators can access NCATS support to advance translational science.
More News & Events …